Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,721.43
(
0.33%
)
US TECH 100
24,122.00
(
0.44%
)
Dow Jones
47,057.60
(
0.24%
)
Brent Oil
99.15
(
0.86%
)
Bitcoin
74,171.70
(
-0.90%
)
News Focus
News Focus
Post# of 257251
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122790
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 49502

Sunday, 11/23/2008 8:03:23 PM

Sunday, November 23, 2008 8:03:23 PM

Post# of 257251
Rep. Dingell and FoB Legislation

The recently announced ouster of Rep. Dingell from the chair of the House Energy and Commerce Committee is a positive development for biotech companies seeking to capitalize on FoB’s. Dingell was one of the main impediments to the enactment of FoB legislation for reasons that have never been clear to me.

As an aside, Dingell has served in the House of Representatives for 54 years (!), longer than all but one person in the history of the USA.


“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now